Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.

Dyskeratosis congenita is a rare inherited disorder characterized by abnormal skin manifestations. Morbidity and mortality from this disease is usually due to bone marrow failure, but idiopathic pulmonary fibrosis and an increased cancer predisposition also occur. Families with autosomal dominant dyskeratosis congenita display anticipation and have mutations in the telomerase RNA gene. We identified a three-generation pedigree with autosomal dominant dyskeratosis congenita, anticipation, and telomere shortening. We show that a null mutation in motif D of the reverse transcriptase domain of the protein component of telomerase, hTERT, is associated with this phenotype. This mutation leads to haploinsufficiency of telomerase, and telomere shortening occurs despite the presence of telomerase. This finding emphasizes the importance of telomere maintenance and telomerase dosage for maintaining tissue proliferative capacity and has relevance for understanding mechanisms of age-related changes.

[1]  S. Chanock,et al.  Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. , 2005, The New England journal of medicine.

[2]  Margaret A. Strong,et al.  Phosphorylation of H2AX at Short Telomeres in T Cells and Fibroblasts* , 2004, Journal of Biological Chemistry.

[3]  Yie Liu,et al.  Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Vulliamy,et al.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC , 2004, Nature Genetics.

[5]  C. Greider,et al.  Template boundary definition in mammalian telomerase. , 2003, Genes & development.

[6]  P. Lansdorp,et al.  Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA , 2003, The Lancet.

[7]  N. Carter,et al.  A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.

[8]  S. Chanock,et al.  Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. , 2003, Blood.

[9]  R. Cawthon,et al.  Association between telomere length in blood and mortality in people aged 60 years or older , 2003, The Lancet.

[10]  C. Greider,et al.  Determinants in mammalian telomerase RNA that mediate enzyme processivity and cross‐species incompatibility , 2003, The EMBO journal.

[11]  Margaret A. Strong,et al.  Haploinsufficiency of mTR results in defects in telomere elongation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Jiunn-Liang Chen,et al.  A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA. , 2002, Nucleic acids research.

[13]  Margaret A. Strong,et al.  The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability , 2001, Cell.

[14]  T. Vulliamy,et al.  The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita , 2001, Nature.

[15]  Margaret A. Strong,et al.  Telomere dysfunction triggers developmentally regulated germ cell apoptosis. , 2001, Molecular biology of the cell.

[16]  S. Doublié,et al.  The Motif D Loop of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Is Critical for Nucleoside 5′-Triphosphate Selectivity* , 1999, The Journal of Biological Chemistry.

[17]  A. Poustka,et al.  X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. , 1999, American journal of human genetics.

[18]  H. Esperou,et al.  Unusual complications after bone marrow transplantation for dyskeratosis congenita , 1998, British journal of haematology.

[19]  María A Blasco,et al.  Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA , 1997, Cell.

[20]  C B Harley,et al.  Telomerase catalytic subunit homologs from fission yeast and human. , 1997, Science.

[21]  T. Shimizu,et al.  Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation , 1997, Bone Marrow Transplantation.

[22]  P. Rudolph,et al.  Simultaneous introduction of multiple mutations using overlap extension PCR. , 1997, BioTechniques.

[23]  L Kruglyak,et al.  Parametric and nonparametric linkage analysis: a unified multipoint approach. , 1996, American journal of human genetics.

[24]  H. Tanke,et al.  Heterogeneity in telomere length of human chromosomes. , 1996, Human molecular genetics.

[25]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[26]  C B Harley,et al.  Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[28]  E. Blackburn,et al.  A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis , 1989, Nature.

[29]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.